L. Monnier

Endocrinology, Diabetes and Metabolism · 2003–2006

A researcher in the Science corpus: 3 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

Whom L. Monnier trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. Antonio Ceriello
  2. S. Kahn

Who trusts L. Monnier overall

  1. Antonio Ceriello

Papers from L. Monnier's perspective

Ordered by how strongly the researchers L. Monnier trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Molecular motors
  2. Acarbose reduces the risk for myocardial infarction in type 2 diabetic patients: meta-analysis of seven long-term studies. (European Heart Journal)
  3. Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial. (The Lancet)
  4. Postprandial hyperglycemia and diabetes complications: is it time to treat? (Diabetes)
  5. Measurement of F(2)-isoprostanes as an index of oxidative stress in vivo. (Free Radical Biology & Medicine)
  6. A systematic review of adherence with medications for diabetes. (Diabetes Care)
  7. The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes (Diabetologia)
  8. Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: variations with increasing levels of HbA(1c). (Diabetes Care)
  9. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage (Nature)
  10. Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational modification at the Akt site. (Journal of Clinical Investigation)

Their papers